Touboul E, Beral H M, Grigoraki V, Raphael M, Taelman P, Chantelard J V, Gabarre J, Bro S, Guerin R A
Centre des Tumeurs, CHU Pitié-Salpêtrière, Paris.
Rev Mal Respir. 1988;5(6):619-27.
We have reported a retrospective study on 24 cases of supra-diaphragmatic Hodgkin's disease Stage I and II, with massive mediastinal invasion, followed from January 1981 to October 1986 and treated first with chemotherapy and then supra-diaphragmatic mantle type radiotherapy up to a dose of 40 Gy in 20 sessions and over 26 days; inverted irradiation was given to the aorto-lumbar region and the spleen up to a dose of 30 Gy in 15 sessions over 19 days. Supplementary irradiation to the superior mediastinum on average 10 Gy in five sessions over five days was given in two cases and five Gy in three sessions over three days in four cases. After initial chemotherapy there appeared to be a complete remission in 29% (7 out of 24), there was a partial remission in 71% (17 out of 24), of which one gave a 25% response, two a 50% response and 14 gave a response of greater than 80%. After radiotherapy the remission rate appeared complete in 96% (23 out of 24). The overall survival was 90% (19 out of 21) with a mean follow up of 45 months (range 8-78 months) with a complete remission level of 85.5% (18 out of 21). For the 13 cases followed for five years the overall survival level and the level of survival in complete remission was 84.5% (11 out of 13) and 77% (10 out of 13) respectively. We have seen symptomatic post radiotherapy pneumonia. The association of chemo and radiotherapy in this limited series of patients has enabled us to obtain a satisfying duration of remission.(ABSTRACT TRUNCATED AT 250 WORDS)
我们报告了一项针对24例膈上霍奇金病I期和II期且伴有大量纵隔侵犯患者的回顾性研究。这些患者于1981年1月至1986年10月期间接受随访,首先接受化疗,然后进行膈上斗篷式放疗,剂量达40 Gy,分20次,在26天以上完成;对腹主动脉-腰区和脾脏进行反向照射,剂量达30 Gy,分15次,在19天以上完成。2例患者对上纵隔平均补充照射5次,共10 Gy,为期5天;4例患者补充照射3次,共5 Gy,为期3天。初始化疗后,29%(24例中的7例)出现完全缓解,71%(24例中的17例)出现部分缓解,其中1例缓解率为25%,2例为50%,14例缓解率大于80%。放疗后,缓解率达96%(24例中的23例)。总生存率为90%(21例中的19例),平均随访45个月(范围8 - 78个月),完全缓解率为85.5%(21例中的18例)。13例随访5年的患者,总生存率和完全缓解生存率分别为84.5%(13例中的11例)和77%(13例中的10例)。我们观察到放疗后有症状性肺炎。在这一有限系列患者中,化疗与放疗联合使用使我们获得了令人满意的缓解期。(摘要截断于250字)